SINTX Technologies Inc’s (SINT) stock surged over 90% after receiving a patent for its zirconia-toughened alumina surface functionalization methods. This technology promises to enhance medical implants by integrating the properties of silicon nitride, leading to improved osseointegration and bacterial resistance. The company is currently the only FDA-registered producer of implantable silicon nitride, positioning itself as a key player in the biomaterials market.